<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28217559</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>A Novel Enterovirus 71 (EV71) Virulence Determinant: The 69th Residue of 3C Protease Modulates Pathogenicity.</ArticleTitle><Pagination><StartPage>26</StartPage><MedlinePgn>26</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">26</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2017.00026</ELocationID><Abstract><AbstractText>Human enterovirus type 71 (EV71), the major causative agent of hand-foot-and-mouth disease, has been known to cause fatal neurological complications. Unfortunately, the reason for neurological complications that have been seen in fatal cases of the disease and the relationship between EV71 virulence and viral genetic sequences remains largely undefined. The 3C protease (3C<sup>pro</sup>) of EV71 plays an irreplaceable role in segmenting the precursor polyprotein during viral replication, and intervening with host life activity during viral infection. In this study, for the first time, the 69th residue of 3C protease has been identified as a novel virulence determinant of EV71. The recombinant virus with single point variation, in the 69th of 3C<sup>pro</sup>, exhibited obvious decline in replication, and virulence. We further determined the crystal structure of 3C N69D at 1.39 &#x1fa; resolution and found that conformation of 3C N69D demonstrated significant changes compared with a normal 3C protein, in the substrate-binding site and catalytic active site. Strikingly, one of the switch loops, essential in fixing substrates, adopts an open conformation in the 3C N69D-rupintrivir complex. Consistent with this apparent structural disruption, the catalytic activity of 3C N69D decreased sharply for host derived and viral derived substrates, detected for both <i>in vitro</i> and <i>in vivo</i>. Interestingly, in addition to EV71, Asp69 was also found in 3C proteases of other virus strains, such as CAV16, and was conserved in nearly all C type human rhinovirus. Overall, we identified a natural virulence determinant of 3C protease and revealed the mechanism of attenuated virulence is mediated by N69D substitution. Our data provides new insight into the enzymatic mechanism of a subdued 3C protease and suggests a theoretical basis for virulence determinantion of picornaviridae.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bingqing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Key Laboratory of Rare and Uncommon Diseases, Department of Microbiology, Institute of Basic Medicine, Shandong Academy of Medical Sciences Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yue</LastName><ForeName>Yingying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Rare and Uncommon Diseases, Department of Microbiology, Institute of Basic Medicine, Shandong Academy of Medical Sciences Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yajie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Rare and Uncommon Diseases, Department of Microbiology, Institute of Basic Medicine, Shandong Academy of Medical Sciences Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Zenglin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Microbial Technology, School of Life Sciences, Shandong University Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Key Laboratory of Rare and Uncommon Diseases, Department of Microbiology, Institute of Basic Medicine, Shandong Academy of Medical Sciences Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Nannan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Key Laboratory of Rare and Uncommon Diseases, Department of Microbiology, Institute of Basic Medicine, Shandong Academy of Medical Sciences Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Key Laboratory of Rare and Uncommon Diseases, Department of Microbiology, Institute of Basic Medicine, Shandong Academy of Medical Sciences Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Rare and Uncommon Diseases, Department of Microbiology, Institute of Basic Medicine, Shandong Academy of Medical Sciences Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Lichuan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Microbial Technology, School of Life Sciences, Shandong University Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Key Laboratory of Rare and Uncommon Diseases, Department of Microbiology, Institute of Basic Medicine, Shandong Academy of Medical Sciences Jinan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050505">Mutant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037521">Virulence Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050505" MajorTopicYN="N">Mutant Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017354" MajorTopicYN="N">Point Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037521" MajorTopicYN="N">Virulence Factors</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3C protease</Keyword><Keyword MajorTopicYN="N">N69D substitution</Keyword><Keyword MajorTopicYN="N">crystal structure</Keyword><Keyword MajorTopicYN="N">human enterovirus type 71</Keyword><Keyword MajorTopicYN="N">virulence determinantion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28217559</ArticleId><ArticleId IdType="pmc">PMC5290453</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2017.00026</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adams P. D., Grosse-Kunstleve R. W., Hung L. W., Ioerger T. R., McCoy A. J., Moriarty N. W., et al. . (2002). PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58, 1948&#x2013;1954. 10.1107/S0907444902016657</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444902016657</ArticleId><ArticleId IdType="pubmed">12393927</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhakat S. (2015). Effect of T68A/N126Y mutations on the conformational and ligand binding landscape of Coxsackievirus B3 3C protease. Mol. Biosyst. 11, 2303&#x2013;2311. 10.1039/C5MB00262A</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5MB00262A</ArticleId><ArticleId IdType="pubmed">26077945</ArticleId></ArticleIdList></Reference><Reference><Citation>Birtley J. R., Knox S. R., Jaulent A. M., Brick P., Leatherbarrow R. J., Curry S. (2005). Crystal structure of foot-and-mouth disease virus 3C protease. New insights into catalytic mechanism and cleavage specificity. J. Biol. Chem. 280, 11520&#x2013;11527. 10.1074/jbc.M413254200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M413254200</ArticleId><ArticleId IdType="pubmed">15654079</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonderoff J. M., Larey J. L., Lloyd R. E. (2008). Cleavage of poly(A)-binding protein by poliovirus 3C proteinase inhibits viral internal ribosome entry site-mediated translation. J. Virol. 82, 9389&#x2013;9399. 10.1128/JVI.00006-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00006-08</ArticleId><ArticleId IdType="pmc">PMC2546981</ArticleId><ArticleId IdType="pubmed">18632855</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao R. Y., Dong D. Y., Liu R. J., Han J. F., Wang G. C., Zhao H., et al. . (2013). Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection. PLoS ONE 8:e64024. 10.1371/journal.pone.0064024</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0064024</ArticleId><ArticleId IdType="pmc">PMC3659118</ArticleId><ArticleId IdType="pubmed">23700449</ArticleId></ArticleIdList></Reference><Reference><Citation>Costenaro L., Kaczmarska Z., Arnan C., Janowski R., Coutard B., Sola M., et al. . (2011). Structural basis for antiviral inhibition of the main protease, 3C, from human enterovirus 93. J. Virol. 85, 10764&#x2013;10773. 10.1128/JVI.05062-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05062-11</ArticleId><ArticleId IdType="pmc">PMC3187475</ArticleId><ArticleId IdType="pubmed">21835784</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S., Wang J., Fan T., Qin B., Guo L., Lei X., et al. . (2011). Crystal structure of human enterovirus 71 3C protease. J. Mol. Biol. 408, 449&#x2013;461. 10.1016/j.jmb.2011.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2011.03.007</ArticleId><ArticleId IdType="pmc">PMC7094522</ArticleId><ArticleId IdType="pubmed">21396941</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasmahapatra B., Didomenico B., Dwyer S., Ma J., Sadowski I., Schwartz J. (1992). A genetic system for studying the activity of a proteolytic enzyme. Proc. Natl. Acad. Sci. U.S.A. 89, 4159&#x2013;4162. 10.1073/pnas.89.9.4159</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.89.9.4159</ArticleId><ArticleId IdType="pmc">PMC525652</ArticleId><ArticleId IdType="pubmed">1570342</ArticleId></ArticleIdList></Reference><Reference><Citation>De Breyne S., Bonderoff J. M., Chumakov K. M., Lloyd R. E., Hellen C. U. (2008). Cleavage of eukaryotic initiation factor eIF5B by enterovirus 3C proteases. Virology 378, 118&#x2013;122. 10.1016/j.virol.2008.05.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2008.05.019</ArticleId><ArticleId IdType="pmc">PMC2580754</ArticleId><ArticleId IdType="pubmed">18572216</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P., Cowtan K. (2004). Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126&#x2013;2132. 10.1107/S0907444904019158</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444904019158</ArticleId><ArticleId IdType="pubmed">15572765</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J. F., Cao R. Y., Tian X., Yu M., Qin E. D., Qin C. F. (2010). Producing infectious enterovirus type 71 in a rapid strategy. Virol. J. 7:116. 10.1186/1743-422X-7-116</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-116</ArticleId><ArticleId IdType="pmc">PMC2892457</ArticleId><ArticleId IdType="pubmed">20525351</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M. (2000). Enterovirus 71: the virus, its infections and outbreaks. J. Microbiol. Immunol. Infect. 33, 205&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">11269363</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C. C., Liu C. C., Chang Y. C., Chen C. Y., Wang S. T., Yeh T. F. (1999). Neurologic complications in children with enterovirus 71 infection. N.Engl. J. Med. 341, 936&#x2013;942. 10.1056/NEJM199909233411302</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411302</ArticleId><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Liu Q., Zhang L., Zhang Q., Hu L., Li C., et al. . (2015). Encephalomyocarditis Virus 3C Protease Relieves TRAF Family Member-associated NF-&#x3ba;B Activator (TANK) Inhibitory Effect on TRAF6-mediated NF-&#x3ba;B Signaling through Cleavage of TANK. J. Biol. Chem. 290, 27618&#x2013;27632. 10.1074/jbc.M115.660761</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.660761</ArticleId><ArticleId IdType="pmc">PMC4646013</ArticleId><ArticleId IdType="pubmed">26363073</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundu P., Raychaudhuri S., Tsai W., Dasgupta A. (2005). Shutoff of RNA polymerase II transcription by poliovirus involves 3C protease-mediated cleavage of the TATA-binding protein at an alternative site: incomplete shutoff of transcription interferes with efficient viral replication. J. Virol. 79, 9702&#x2013;9713. 10.1128/JVI.79.15.9702-9713.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.15.9702-9713.2005</ArticleId><ArticleId IdType="pmc">PMC1181600</ArticleId><ArticleId IdType="pubmed">16014932</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo C. J., Shie J. J., Fang J. M., Yen G. R., Hsu J. T., Liu H. G., et al. . (2008). Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. Bioorg. Med. Chem. 16, 7388&#x2013;7398. 10.1016/j.bmc.2008.06.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2008.06.015</ArticleId><ArticleId IdType="pmc">PMC7125518</ArticleId><ArticleId IdType="pubmed">18583140</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuyumcu-Martinez M., Belliot G., Sosnovtsev S. V., Chang K. O., Green K. Y., Lloyd R. E. (2004a). Calicivirus 3C-like proteinase inhibits cellular translation by cleavage of poly(A)-binding protein. J. Virol. 78, 8172&#x2013;8182. 10.1128/JVI.78.15.8172-8182.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.8172-8182.2004</ArticleId><ArticleId IdType="pmc">PMC446144</ArticleId><ArticleId IdType="pubmed">15254188</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuyumcu-Martinez N. M., Van Eden M. E., Younan P., Lloyd R. E. (2004b). Cleavage of poly(A)-binding protein by poliovirus 3C protease inhibits host cell translation: a novel mechanism for host translation shutoff. Mol. Cell. Biol. 24, 1779&#x2013;1790. 10.1128/MCB.24.4.1779-1790.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.24.4.1779-1790.2004</ArticleId><ArticleId IdType="pmc">PMC344173</ArticleId><ArticleId IdType="pubmed">14749392</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C. C., Kuo C. J., Ko T. P., Hsu M. F., Tsui Y. C., Chang S. C., et al. . (2009). Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds. J. Biol. Chem. 284, 7646&#x2013;7655. 10.1074/jbc.M807947200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M807947200</ArticleId><ArticleId IdType="pmc">PMC2658058</ArticleId><ArticleId IdType="pubmed">19144641</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Han N., Xiao X., Jin Q., He B., Wang J. (2014). Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB1/TAB2/TAB3 complex. J. Virol. 88, 9830&#x2013;9841. 10.1128/JVI.01425-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01425-14</ArticleId><ArticleId IdType="pmc">PMC4136319</ArticleId><ArticleId IdType="pubmed">24942571</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Liu X., Ma Y., Sun Z., Yang Y., Jin Q., et al. . (2010). The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 84, 8051&#x2013;8061. 10.1128/JVI.02491-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02491-09</ArticleId><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Sun Z., Liu X., Jin Q., He B., Wang J. (2011). Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 85, 8811&#x2013;8818. 10.1128/JVI.00447-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00447-11</ArticleId><ArticleId IdType="pmc">PMC3165803</ArticleId><ArticleId IdType="pubmed">21697485</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Xiao X., Xue Q., Jin Q., He B., Wang J. (2013). Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J. Virol. 87, 1690&#x2013;1698. 10.1128/JVI.01855-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01855-12</ArticleId><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Li N., Wang F., Guo L., Huang Y., Liu X., et al. . (2012). Structural insight of a concentration-dependent mechanism by which YdiV inhibits Escherichia coli flagellum biogenesis and motility. Nucleic Acids Res. 40, 11073&#x2013;11085. 10.1093/nar/gks869</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks869</ArticleId><ArticleId IdType="pmc">PMC3510510</ArticleId><ArticleId IdType="pubmed">23002140</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M. L., Hsu T. A., Chen T. C., Chang S. C., Lee J. C., Chen C. C., et al. . (2002). The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology 293, 386&#x2013;395. 10.1006/viro.2001.1310</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1310</ArticleId><ArticleId IdType="pubmed">11886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Yue Y., Song N., Li B., Meng H., Yang G., et al. . (2016). Genome analysis of enterovirus 71 strains differing in mouse pathogenicity. Virus Genes. 2, 1&#x2013;11. 10.1007/s11262-015-1271-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-015-1271-0</ArticleId><ArticleId IdType="pubmed">26781949</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Liu L., Mo Z., Wang X., Xia J., Liang Z., et al. . (2014). An inactivated enterovirus 71 vaccine in healthy children. N.Engl. J. Med. 370, 829&#x2013;837. 10.1056/NEJMoa1303224</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303224</ArticleId><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z. H., Yue Y. Y., Li P., Song N. N., Li B., Zhang Y., et al. . (2015). MA104 Cell line presents characteristics suitable for enterovirus A71 isolation and proliferation. Microbiol. Immunol. 59, 477&#x2013;482. 10.1111/1348-0421.12281</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1348-0421.12281</ArticleId><ArticleId IdType="pubmed">26138857</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu G., Qi J., Chen Z., Xu X., Gao F., Lin D., et al. . (2011). Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design. J. Virol. 85, 10319&#x2013;10331. 10.1128/JVI.00787-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00787-11</ArticleId><ArticleId IdType="pmc">PMC3196414</ArticleId><ArticleId IdType="pubmed">21795339</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum L. C., Wong K. T., Lam S. K., Chua K. B., Goh A. Y., Lim W. L., et al. . (1998). Fatal enterovirus 71 encephalomyelitis. J. Pediatr. 133, 795&#x2013;798. 10.1016/S0022-3476(98)70155-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(98)70155-6</ArticleId><ArticleId IdType="pubmed">9842048</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P. C. (2002). An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26, 91&#x2013;107. 10.1111/j.1574-6976.2002.tb00601.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng T., Kwang J. (2014). Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice. J. Virol. 88, 5803&#x2013;5815. 10.1128/JVI.00289-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00289-14</ArticleId><ArticleId IdType="pmc">PMC4019108</ArticleId><ArticleId IdType="pubmed">24623423</ArticleId></ArticleIdList></Reference><Reference><Citation>Parks G. D., Baker J. C., Palmenberg A. C. (1989). Proteolytic cleavage of encephalomyocarditis virus capsid region substrates by precursors to the 3C enzyme. J. Virol. 63, 1054&#x2013;1058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC247798</ArticleId><ArticleId IdType="pubmed">2536819</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich S. H., Johnson T., Wallace M. B., Kephart S. E., Fuhrman S. A., Worland S. T., et al. . (2000). Substituted benzamide inhibitors of human rhinovirus 3C protease: structure-based design, synthesis, and biological evaluation. J. Med. Chem. 43, 1670&#x2013;1683. 10.1021/jm9903242</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm9903242</ArticleId><ArticleId IdType="pubmed">10794684</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindarov L. M., Chumakov M. P., Voroshilova M. K., Bojinov S., Vasilenko S. M., Iordanov I., et al. . (1979). Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J. Hyg. Epidemiol. Microbiol. Immunol. 23, 284&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pubmed">231067</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong R., Belsham G. J. (2004). Sequential modification of translation initiation factor eIF4GI by two different foot-and-mouth disease virus proteases within infected baby hamster kidney cells: identification of the 3Cpro cleavage site. J. Gen. Virol. 85, 2953&#x2013;2962. 10.1099/vir.0.80254-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.80254-0</ArticleId><ArticleId IdType="pubmed">15448358</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Fan T., Yao X., Wu Z., Guo L., Lei X., et al. . (2011). Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues. J. Virol. 85, 10021&#x2013;10030. 10.1128/JVI.05107-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05107-11</ArticleId><ArticleId IdType="pmc">PMC3196404</ArticleId><ArticleId IdType="pubmed">21813612</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Yang B., Zhai Y., Yin Z., Sun Y., Rao Z. (2015). Peptidyl aldehyde NK-1.8k suppresses enterovirus 71 and enterovirus 68 infection by targeting protease 3C. Antimicrob. Agents Chemother. 59, 2636&#x2013;2646. 10.1128/AAC.00049-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00049-15</ArticleId><ArticleId IdType="pmc">PMC4394787</ArticleId><ArticleId IdType="pubmed">25691647</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng K. F., Chen L. L., Huang P. N., Shih S. R. (2010). Neural pathogenesis of enterovirus 71 infection. Microbes Infect. 12, 505&#x2013;510. 10.1016/j.micinf.2010.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2010.03.006</ArticleId><ArticleId IdType="pubmed">20348010</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng K. F., Li M. L., Hung C. T., Shih S. R. (2009). Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog. 5:e1000593. 10.1371/journal.ppat.1000593</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000593</ArticleId><ArticleId IdType="pmc">PMC2742901</ArticleId><ArticleId IdType="pubmed">19779565</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C., Cai Q., Chen C., Li N., Peng X., Cai Y., et al. . (2013). Structures of Enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir. Acta Crystallogr. D Biol. Crystallogr. 69, 866&#x2013;871. 10.1107/S0907444913002862</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444913002862</ArticleId><ArticleId IdType="pubmed">23633597</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z., Li L., Lei X., Zhou H., Zhou Z., He B., et al. . (2014). Enterovirus 68 3C protease cleaves TRIF to attenuate antiviral responses mediated by Toll-like receptor 3. J. Virol. 88, 6650&#x2013;6659. 10.1128/JVI.03138-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03138-13</ArticleId><ArticleId IdType="pmc">PMC4054379</ArticleId><ArticleId IdType="pubmed">24672048</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., Ren L., Xiong Z., Li J., Xiao Y., Zhao R., et al. . (2009). Enterovirus 71 outbreak in the People's Republic of China in 2008. J. Clin. Microbiol. 47, 2351&#x2013;2352. 10.1128/JCM.00563-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00563-09</ArticleId><ArticleId IdType="pmc">PMC2708525</ArticleId><ArticleId IdType="pubmed">19439545</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S., Li G., Wang Y., Gao Q., Wang Y., Cui R., et al. . (2015). Identification of positively charged residues in enterovirus 71 capsid protein VP1 essential for production of infectious particles. J. Virol. 90, 741&#x2013;752. 10.1128/JVI.02482-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02482-15</ArticleId><ArticleId IdType="pmc">PMC4702679</ArticleId><ArticleId IdType="pubmed">26512078</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Wu X., Huang K., Li L., Zheng L., Wan C., et al. . (2014). The variations of VP1 protein might be associated with nervous system symptoms caused by enterovirus 71 infection. BMC Infect. Dis. 14:243. 10.1186/1471-2334-14-243</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-243</ArticleId><ArticleId IdType="pmc">PMC4101859</ArticleId><ArticleId IdType="pubmed">24886383</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F., Xu W., Xia J., Liang Z., Liu Y., Zhang X., et al. . (2014). Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N.Engl. J. Med. 370, 818&#x2013;828. 10.1056/NEJMoa1304923</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1304923</ArticleId><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Zunszain P. A., Knox S. R., Sweeney T. R., Yang J., Roque-Rosell N., Belsham G. J., et al. . (2010). Insights into cleavage specificity from the crystal structure of foot-and-mouth disease virus 3C protease complexed with a peptide substrate. J. Mol. Biol. 395, 375&#x2013;389. 10.1016/j.jmb.2009.10.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2009.10.048</ArticleId><ArticleId IdType="pmc">PMC7099390</ArticleId><ArticleId IdType="pubmed">19883658</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>